Ledger.Open graph →
SEC Form D · filed May 27, 2020

Algernon Pharmaceuticals Inc

Offering
$128K
Sold
$50K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Christopher Moreau · Vancouver, British Columbia, CanadaExecMichael Sadhra · Vancouver, British Columbia, CanadaExec · DirectorDavid Levine · Vancouver, British Columbia, CanadaDirectorRaj Attariwala · Vancouver, British Columbia, CanadaDirectorJim Mccabe · Fort Lauderdale, FLExec · DirectorJames Iuliano · Santa Barbara, CAExecDana Stalder · San Francisco, CADirectorSimon S. Zhang · Irvine, CADirectorDavid Persing · BURLINGAME, CADirectorSteven Tablak · BURLINGAME, CAExec · DirectorMichael Rubin · BURLINGAME, CADirectorJacob B. Frieberg · Rochester, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗